$231.29
+2.90 (+1.27%)
At Close: Jun 22, 2026
Tremfya, Icotyde Lead J&J's Post-Stelara Immunology Strategy
12:56pm, Tuesday, 12'th May 2026
JNJ bets on Tremfya and newly approved Icotyde to drive immunology growth as Stelara faces biosimilar pressure.
Johnson & Johnson Advances the Standard of Calcium Modification with Global Launch of Shockwave™ C2 Aero Coronary IVL Catheter
07:45am, Tuesday, 12'th May 2026
SANTA CLARA, Calif.--(BUSINESS WIRE)--Johnson & Johnson Advances the Standard of Calcium Modification with Global Launch of Shockwave™ C2 Aero Coronary IVL Catheter.
Johnson & Johnson to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
04:34pm, Monday, 11'th May 2026
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on Tuesday, June 9th, 2026. Management will participa
Income or Growth: Which Healthcare Stock Fits Your Portfolio Right Now?
03:30pm, Monday, 11'th May 2026
It's important to look beyond near-term volatility.
Johnson & Johnson reinforces its leadership in advancing neuropsychiatry with new portfolio and pipeline data at APA and ASCP
08:00am, Monday, 11'th May 2026
Oral presentations feature CAPLYTA ® long-term data assessing relapse risk reduction in schizophrenia and new seltorexant analyses in major depressive disorder (MDD) with insomnia symptoms 18 abstrac
Is JNJ Overvalued? DCF Says Worth $122
07:25am, Monday, 11'th May 2026
On May 11, 2026, we present a detailed DCF analysis for Johnson and Johnson (JNJ), a company that has shown varied price performance recently. Over the past week,
2 Dividend Stocks That Are No-Brainer Buys in May
10:15am, Sunday, 10'th May 2026
The geopolitical conflict in the Middle East has pushed oil prices higher and increased concerns about a recession. The S&P 500 index continues to hold near its all-time highs.
A $500,000 Dividend Portfolio That Pays More Than a Full-Time Minimum Wage Job
11:30am, Saturday, 09'th May 2026
A full-time federal minimum wage worker in the United States earns $7.25 an hour, or about $15,080 a year before taxes, working 40 hours a week for 52 weeks. The question for anyone with capital: what
Nationwide Survey: 83% of Americans Are Worried Social Security Won’t Survive, and Here’s What to Do About It
12:41pm, Friday, 08'th May 2026
The fear is loud, and the data backs it up. According to the Nationwide Retirement Institute's 2025 Social Security Survey, 83% of Americans currently receiving or expecting to receive Social Security
3 Unstoppable Dividend King Stocks to Buy Right Now for Less Than $550
08:00am, Friday, 08'th May 2026
These companies pay some of the world's most bankable dividends.
Warren Buffett and Berkshire Hathaway Own 2 Dividend Kings That Will Never Be Sold
07:50am, Friday, 08'th May 2026
Warren Buffett stepped down as CEO of Berkshire Hathaway (BRK-B | BRK.B Price Prediction) on December 31, 2025, after six decades leading the conglomerate he transformed from a struggling textile mill
Darzalex, Erleada & New Drugs Keep J&J's Oncology Engine Charged in Q1
12:46pm, Thursday, 07'th May 2026
Darzalex and new launches fuel J&J's 17.8% oncology sales growth in Q1 as the company targets $50B in cancer sales by 2030.
This Dividend Pro Likes Banks, Semi-Equipment Stocks, Altria, and J&J
11:34am, Thursday, 07'th May 2026
Michael Barclay, lead manager of the Columbia Dividend Income fund, favors dividend growers over high yields.
Generation Fine launches after global survey finds nearly 4 in 5 patients living with major depressive disorder don't believe antidepressants will help them reach remission Campaign draws on expertise
Safer Dividend King to Buy Now: AbbVie or Johnson & Johnson?
04:00pm, Wednesday, 06'th May 2026
They have combined for 118 years of consecutive dividend increases.
Sign In
Buy JNJ